|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 35/02 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07K 16/30 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3394103 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16826557.7 |
| Date of filing the European patent application | 2016-12-21 | |
| (97) | Date of publication of the European application | 2018-10-31 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-28 |
| (46) | Date of publication of the claims translation | 2023-09-11 |
| (86) | Number | PCT/US2016/068030 |
| Date | 2016-12-21 |
| (87) | Number | WO 2017/112775 |
| Date | 2017-06-29 |
| (30) | Number | Date | Country code |
| 201562270749 P | 2015-12-22 | US |
| (72) |
VARGHESE, Bindu , US
THURSTON, Gavin , US
LOWY, Israel , US
BROWNSTEIN, Carrie , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnų prieš PD-1 ir bispecifinių antikūnų prieš CD20/CD3 derinys, skirtas vėžiui gydyti |
| COMBINATION OF ANTI-PD-1 ANTIBODIES AND BISPECIFIC ANTI-CD20/ANTI-CD3 ANTIBODIES TO TREAT CANCER |
| Payment date | Validity (years) | Amount | |
| 2024-11-21 | 9 | 208.00 EUR |
| 2025-12-21 |